ClinicalTrials.gov
public full text
Public Domain
Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
This clinical trial studies how well delayed fludeoxyglucose F-18 (18F-FDG) positron emission tomography (PET)/computed tomography (CT) works in improving visualization of brain tumors in patients with glioblastoma. Radiotracers such as 18F-FDG are highly taken up by tumors in the brain and are visualized using PET/CT. Increasing the interval of time between 18F-FDG administration and PET/CT scan may improve the visualization of brain tumors in patients with glioblastoma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of the Value of Cerebral Perfusion Scintigraphy in the Study of Post-stroke Fatigability#834238
- Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma#979824
- Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival.#396025
- Non-Helium Magnetoencephalography in Pediatric Brain Tumors#1139381
- PETPVC: a toolbox for performing partial volume correction techniques in positron emission tomography#1090648
Record · ID 833213
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive